🇺🇸 FDA
Pipeline program

Sotagliflozin

LX4211.1-314-HCM

Phase 3 small_molecule active

Quick answer

Sotagliflozin for Obstructive Cardiomyopathy, Hypertrophic is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LEXICON PHARMACEUTICALS, INC.
Indication
Obstructive Cardiomyopathy, Hypertrophic
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials